Tekla Healthcare Investors
NYSE:HQH
15.2 (USD) • At close May 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q2 | 2014 Q4 | 2014 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 5.464 | 5.305 | 4.664 | 5.628 | 4.315 | 3.956 | 3.216 | 3.265 | 3.912 | 5.021 | 3.891 | 3.71 | 3.789 | 2.995 | 2.798 | 2.821 | 2.47 | 2.331 | 2.724 | 1.607 | 1.169 | 0.975 |
| Kosten van de omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Brutowinst
| 5.464 | 5.305 | 4.664 | 5.628 | 4.315 | 3.956 | 3.216 | 3.265 | 3.912 | 5.021 | 3.891 | 3.71 | 3.789 | 2.995 | 2.798 | 2.821 | 2.47 | 2.331 | 2.724 | 1.607 | 1.169 | 0.975 |
| Brutowinstmarge
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Onderzoek- en ontwikkelingskosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 5.615 | 5.318 | 5.686 | 5.791 | 5.748 | 6.193 | 6.551 | 6.16 | 5.685 | 5.22 | 5.15 | 5.323 | 5.458 | 5.447 | 5.599 | 5.184 | 5.289 | 5.796 | 6.433 | 5.749 | 4.926 | 4.375 |
| Verkoop- en marketingkosten
| 0.038 | 0.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 5.653 | 5.336 | 5.686 | 5.791 | 5.748 | 6.193 | 6.551 | 6.16 | 5.685 | 5.22 | 5.15 | 5.323 | 5.458 | 5.447 | 5.599 | 5.184 | 5.289 | 5.796 | 6.433 | 5.749 | 4.926 | 4.375 |
| Overige kosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bedrijfskosten
| 5.653 | 5.336 | 5.686 | 5.791 | 5.748 | 6.193 | 6.551 | 6.16 | 5.685 | 5.22 | 5.15 | 5.323 | 5.458 | 5.447 | 5.599 | 5.184 | 5.289 | 5.796 | 6.433 | 5.749 | 4.926 | 4.375 |
| Bedrijfsresultaat
| -0.189 | -0.031 | -1.022 | -0.163 | -1.433 | -2.237 | -3.335 | -2.895 | -1.773 | -0.198 | -1.259 | -1.613 | -1.668 | -2.452 | -2.801 | -2.364 | -2.819 | -3.465 | -3.709 | -4.142 | -3.757 | -3.4 |
| Bedrijfsresultaat ratio
| -0.035 | -0.006 | -0.219 | -0.029 | -0.332 | -0.566 | -1.037 | -0.887 | -0.453 | -0.04 | -0.324 | -0.435 | -0.44 | -0.819 | -1.001 | -0.838 | -1.141 | -1.486 | -1.362 | -2.576 | -3.214 | -3.487 |
| Totaal overige inkomsten en kosten netto
| 85.438 | 99.729 | -25.806 | 83.326 | -77.748 | -112.811 | 69.942 | 91.464 | 194.947 | 48.229 | -59.641 | -82.782 | 136.381 | -63.057 | 88.379 | 38.068 | 65.301 | -115.037 | -105.257 | 209.273 | 132.512 | 96.662 |
| Inkomen voor belasting
| 85.249 | 99.697 | -26.828 | 83.163 | -79.181 | -115.048 | 66.607 | 88.569 | 193.174 | 48.031 | -60.901 | -84.394 | 134.713 | -65.509 | 85.578 | 35.705 | 62.482 | -118.501 | -108.966 | 205.132 | 128.756 | 93.261 |
| Inkomen voor belasting ratio
| 15.602 | 18.792 | -5.752 | 14.777 | -18.35 | -29.084 | 20.714 | 27.129 | 49.38 | 9.566 | -15.653 | -22.746 | 35.552 | -21.876 | 30.581 | 12.658 | 25.292 | -50.837 | -40.001 | 127.609 | 110.137 | 95.651 |
| Belastingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Nettowinst
| 85.249 | 99.697 | -26.828 | 83.163 | -79.181 | -115.048 | 66.607 | 88.569 | 193.174 | 48.031 | -60.901 | -84.394 | 134.713 | -65.509 | 85.578 | 35.705 | 62.482 | -118.501 | -108.966 | 205.132 | 128.756 | 93.261 |
| Nettowinstmarge
| 15.602 | 18.792 | -5.752 | 14.777 | -18.35 | -29.084 | 20.714 | 27.129 | 49.38 | 9.566 | -15.653 | -22.746 | 35.552 | -21.876 | 30.581 | 12.658 | 25.292 | -50.837 | -40.001 | 127.609 | 110.137 | 95.651 |
| WPA (Winst Per Aandeel)
| 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 | 4.33 | 1.11 | -1.41 | -1.99 | 3.14 | -1.58 | 2.06 | 0.9 | 1.57 | -3.1 | -2.86 | 5.62 | 2.97 | 3.3 |
| Verwaterde WPA
| 1.59 | 1.97 | -0.53 | 1.72 | -1.64 | -2.48 | 1.44 | 1.98 | 4.33 | 1.11 | -1.41 | -1.99 | 3.14 | -1.58 | 2.06 | 0.9 | 1.57 | -3.1 | -2.86 | 5.62 | 2.97 | 3.3 |
| EBITDA
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |